No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs234584 |
chr14:97092803-97092804 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
2 |
rs147003678 |
chr14:97092809-97092810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs138141983 |
chr14:97092856-97092857 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs534059868 |
chr14:97092862-97092863 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs552721859 |
chr14:97092875-97092876 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs34048492 |
chr14:97092880-97092881 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs552014829 |
chr14:97092887-97092888 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs191203726 |
chr14:97092917-97092918 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs556846694 |
chr14:97092935-97092936 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs143616391 |
chr14:97092959-97092960 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs367759588 |
chr14:97092996-97092997 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs113876277 |
chr14:97093015-97093016 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs553823621 |
chr14:97093040-97093041 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs527961389 |
chr14:97093041-97093042 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs545622772 |
chr14:97093098-97093099 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs17214379 |
chr14:97093113-97093114 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs368110022 |
chr14:97093151-97093152 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs576112248 |
chr14:97093169-97093170 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs183753192 |
chr14:97093170-97093171 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs145397164 |
chr14:97093177-97093178 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs370750248 |
chr14:97093178-97093179 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs369489595 |
chr14:97093255-97093256 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs372765115 |
chr14:97093291-97093292 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs188215993 |
chr14:97093302-97093303 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs529173179 |
chr14:97093342-97093343 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs192386732 |
chr14:97093358-97093359 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs150863151 |
chr14:97093421-97093422 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs527775570 |
chr14:97093439-97093440 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs552437014 |
chr14:97093473-97093474 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs527992561 |
chr14:97093505-97093506 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570927887 |
chr14:97093518-97093519 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs185570525 |
chr14:97093526-97093527 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs550409999 |
chr14:97093542-97093543 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541333702 |
chr14:97093545-97093546 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs531782381 |
chr14:97093568-97093569 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs550000429 |
chr14:97093594-97093595 |
Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs79173552 |
chr14:97093636-97093637 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs4905510 |
chr14:97093659-97093660 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
39 |
rs138221190 |
chr14:97093666-97093667 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs11847868 |
chr14:97093680-97093681 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs149578448 |
chr14:97093692-97093693 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs17094229 |
chr14:97093700-97093701 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs79746329 |
chr14:97093731-97093732 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs555172018 |
chr14:97093735-97093736 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs573581677 |
chr14:97093739-97093740 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs144244012 |
chr14:97093752-97093753 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs71873019 |
chr14:97093773-97093774 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs77979618 |
chr14:97093797-97093798 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs75012727 |
chr14:97093815-97093816 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs531600278 |
chr14:97093834-97093835 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|